查找临床试验
已按「胰腺癌」检索，对应国际通用词 pancreatic cancer
共找到 12 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 10:07，每 5 分钟自动同步正在招募不适用中国有中心NCT07382791
Delayed Gastric Emptying After Pancreatic Surgery
Taiwan
年龄 20 Years – 75 Years
National Taiwan University Hospital
正在招募II 期中国有中心NCT06584227
Adebrelimab and Chidamide for Pancreatic Cancer
China
年龄 18 Years – 75 Years
Liu Xiufeng
正在招募II 期中国有中心NCT05859750
A Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer
China
年龄 18 Years – 75 Years
Akeso
正在招募II 期中国有中心NCT06760819
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
United States、Australia、Canada、China、Denmark 等 11 国
年龄 18 Years – 不限
Bayer
正在招募不适用中国有中心NCT06849063
Assessment of the Prognosis of Pancreatic Cancer Patients Using 3D MRE
China
年龄 18 Years – 80 Years
Yu Shi
正在招募I 期 / II 期中国有中心NCT06959615
A Phase I/IIa Study of JAB-23E73 in Patients With Advanced Solid Tumors Harboring KRAS Gene Alteration
China
年龄 不限 – 不限
Jacobio Pharmaceuticals Co., Ltd.
正在招募早期 I 期中国有中心NCT07595237
A IIT Study of 177Lu-DOTA-SNA040
China
年龄 18 Years – 75 Years
SmartNuclide Biopharma
正在招募不适用中国有中心NCT06715839
Target-specific immunoPET Imaging of Digestive System Carcinoma
China
年龄 18 Years – 75 Years
RenJi Hospital
正在招募不适用中国有中心NCT06040801
Effect of Geriatric Intervention in Frail Patients with Gastric, Biliary, and Pancreatic Cancer Receiving Palliative Chemotherapy
Taiwan
年龄 65 Years – 不限
Chang Gung Memorial Hospital
正在招募I 期 / II 期中国有中心NCT03093688
Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor
China
年龄 18 Years – 70 Years
Shanghai Public Health Clinical Center
正在招募早期 I 期中国有中心NCT06326736
Study of Neoantigen mRNA Vaccines in Patients With Resectable Pancreatic Cancer
China
年龄 18 Years – 75 Years
Jinling Hospital, China
正在招募I 期 / II 期中国有中心NCT06730009
Phase I/II Study: Allogeneic NK-cell Therapy With Chemotherapy for Post-Surgery PDA or Cholangiocarcinoma Patients
Taiwan
年龄 18 Years – 不限
Medigen Biotechnology Corporation